318 related articles for article (PubMed ID: 3793848)
1. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
2. Plasma growth hormone responses to sulpiride in patients with acromegaly.
Hanew K; Sato S; Sasaki A; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1984 Apr; 142(4):445-52. PubMed ID: 6429896
[TBL] [Abstract][Full Text] [Related]
3. The dopaminergic regulation of plasma growth hormone secretion in normal subjects.
Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Yoshinaga K
Tohoku J Exp Med; 1986 Feb; 148(2):151-8. PubMed ID: 3961796
[TBL] [Abstract][Full Text] [Related]
4. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
[TBL] [Abstract][Full Text] [Related]
5. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
[TBL] [Abstract][Full Text] [Related]
6. Evidences for a dopamine-regulated peripheral source of circulating beta-endorphin.
Genazzani AR; Petraglia F; Facchinetti F; Golinelli S; Oltramari P; Santoro V; Volpe A
J Clin Endocrinol Metab; 1988 Feb; 66(2):279-82. PubMed ID: 2963016
[TBL] [Abstract][Full Text] [Related]
7. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man.
Vance ML; Kaiser DL; Frohman LA; Rivier J; Vale WW; Thorner MO
J Clin Endocrinol Metab; 1987 Jun; 64(6):1136-41. PubMed ID: 3553220
[TBL] [Abstract][Full Text] [Related]
8. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
Dunn PJ; Donald RA; Espiner EA
Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
[TBL] [Abstract][Full Text] [Related]
11. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
Müller EE; Salerno F; Cocchi D; Locatelli V; Panerai AE
Clin Endocrinol (Oxf); 1979 Dec; 11(6):645-56. PubMed ID: 119594
[TBL] [Abstract][Full Text] [Related]
14. Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in agromegalic patients.
Verde G; Oppizzi G; Colussi G; Cremascoli G; Botalla L; Müller EE; Silvestrini F; Chiodini PG; Liuzzi A
Clin Endocrinol (Oxf); 1976 Jul; 5(4):419-23. PubMed ID: 971548
[TBL] [Abstract][Full Text] [Related]
15. Evidence for lactotroph dopamine resistance in idiopathic hyperprolactinemia.
Webb CB; Thominet JL; Barowsky H; Berelowitz M; Frohman LA
J Clin Endocrinol Metab; 1983 Jun; 56(6):1089-93. PubMed ID: 6841551
[TBL] [Abstract][Full Text] [Related]
16. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine].
Carmina E; Lanzara P; Lo Coco R; Longo RA; Jannì A
Arch Sci Med (Torino); 1979; 136(3):421-5. PubMed ID: 549547
[TBL] [Abstract][Full Text] [Related]
17. Different effects of metoclopramide and domperidone on GH release in type I male diabetics.
Volpi R; Coiro V; Castelli A; Cappagli M; Muzzetto P; Sciarra A; Chiodera P
Horm Metab Res; 1984 Dec; 16 Suppl 1():131-3. PubMed ID: 6532934
[TBL] [Abstract][Full Text] [Related]
18. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women].
Masaoka K; Hosoya N; Mori T; Watanabe H; Ohkura T; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310
[TBL] [Abstract][Full Text] [Related]
19. Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors.
Wong AO; Chang JP; Peter RE
Endocrinology; 1992 Mar; 130(3):1201-10. PubMed ID: 1347006
[TBL] [Abstract][Full Text] [Related]
20. The effect of dopamine antagonists and/or VIP on TRH- or VIP-induced prolactin release in estrogen- and progesterone-treated ovariectomized rats.
Haisenleder DJ; Moy JA; Gala RR; Lawson DM
Proc Soc Exp Biol Med; 1988 Mar; 187(3):341-9. PubMed ID: 3126503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
